×

논문명
Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma
발표지
J Neurooncol
발표년월
2019
공동연구자
Kim WJ, Dho YS, Ock CY, et al.

논문명
Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study
발표지
Oncologist
발표년월
2019
공동연구자
Jung M, Kim S, Lee JK, et al.

논문명
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
발표지
Am J Hematol
발표년월
2018
공동연구자
Gambacorti-Passerini C, Orlov S, Zhang L, et al.

논문명
A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma
발표지
Oncologist
발표년월
2018
공동연구자
Kim M, Kim TM, Keam B, et al.

논문명
Phase 1 Studies of Poziotinib, an Irreversible Pan-HER Tyrosine Kinase Inhibitor in Patients with Advanced Solid Tumors
발표지
Cancer Res Treat
발표년월
2018
공동연구자
Kim TM, Lee KW, Oh DY, et al.

논문명
Comparison of Native Escherichia Coli L-Asparaginase Versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone (IMEP), in Extranodal NK/T Cell Lymphoma, Nasal Type (NTCL)
발표지
Cancer Res Treat
발표년월
2018
공동연구자
Kim HJ, Ock CY, Kim TM, et al.

논문명
Complex Chromosomal Rearrangements by Single Catastrophic Pathogenesis in NUT Midline Carcinoma
발표지
Ann Oncol
발표년월
2017
공동연구자
Lee JK, Louzada S, An Y, et al.

논문명
Novel JAK3-Activating Mutations in Extranodal NK/T-cell Lymphoma, Nasal Type
발표지
Am J Pathol
발표년월
2017
공동연구자
Sim SH, Kim S, Kim TM, et al.

논문명
Clonal History and Genetic Predictors of Transformation into Small Cell Carcinomas from Lung Adenocarcinomas
발표지
J Clin Oncol
발표년월
2017
공동연구자
Lee JK, LeeJ, Kim S, et al.

논문명
Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications
발표지
Leuk Lymphoma
발표년월
2017
공동연구자
Paik JH, Choe YJ, Kim H, et al.

논문명
Phase I study of random, healthy donor-derived allogeneic natural killer cell therapy in patients with malignant lymphoma or advanced solid tumors
발표지
Cancer Immunol Res
발표년월
2016
공동연구자
Yang Y, Lim O, Kim TM, et al.

논문명
Mechanisms of Acquired Resistance to AZD9291, a Mutation-Selective, Irreversible EGFR Inhibitor
발표지
J Thorac Oncol
발표년월
2015
공동연구자
Kim TM, Song A, Kim DW, et al.

논문명
Total Lesion Glycolysis in Positron Emission Tomography Can Predict Gefitinib Outcomes in Non-Small-Cell Lung Cancer with Activating EGFR Mutation
발표지
J Thorac Oncol
발표년월
2015
공동연구자
Keam B, Lee SJ, Kim TM, et al.

논문명
Molecular changes associated with acquired resistance to crizotinib in ROS1-rearranged non-small cell lung cancer (NSCLC)
발표지
Clin Cancer Res
발표년월
2015
공동연구자
Song A, Kim TM, Kim DW, et al.

논문명
Ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) plus L-asparaginase as a first-line therapy improves outcomes in stage III/IV NK/T cell-lymphoma, nasal type (NTCL)
발표지
Ann Hematol
발표년월
2015
공동연구자
Kim M, Kim TM, Kim KH, et al.

논문명
An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients
발표지
Int J Cancer
발표년월
2015
공동연구자
An YJ, Cho HR, Kim TM, et al.

논문명
A Phase II Study of Ifosfamide, Methotrexate, Etoposide, and Prednisolone for Previously Untreated Stage I/II Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Multicenter Trial of the Korean Cancer Study Group
발표지
Oncologist
발표년월
2014
공동연구자
Kim TM, Kim DW, Kang YK, et al.

논문명
Anti-cancer activity of gemcitabine against natural killer (NK) cell leukemia-lymphoma
발표지
Leuk Lymphoma
발표년월
2014
공동연구자
Kim TM, Kim S, Ahn YO, et al.

논문명
Total lesion glycolysis in positron emission tomography is a better predictor of outcome than the International Prognostic Index for patients with diffuse large B-cell lymphoma.
발표지
Cancer
발표년월
2013
공동연구자
Kim TM, Paeng JC, Chun IK, et al.

논문명
Heterogeneity of Genetic Changes Associated with Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancer.
발표지
J Thorac Oncol
발표년월
2013
공동연구자
Kim S, Kim TM, Kim DW, et al.